Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108277
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108277
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108277
Table 1 General information and demographic characteristics of patients, n (%)
Items | Non-PNI group (n = 17) | PNI group (n = 65) | t | P value |
Age (years), mean ± SD | 60.42 ± 4.36 | 59.87 ± 3.25 | 0.485 | 0.633 |
Gender (male/female) | 10 (58.82)/7(41.18) | 33 (50.77)/32 (49.23) | 0.102 | 0.749 |
BMI (kg/cm2), mean ± SD | 25.64 ± 2.98 | 24.85 ± 2.67 | 0.987 | 0.334 |
Course of disease (months), mean ± SD | 5.46 ± 1.87 | 5.67 ± 2.01 | 0.411 | 0.684 |
Smoking history (yes/no) | 7 (41.18) | 24 (36.92) | 0.002 | 0.967 |
Drinking history (yes/no) | 8 (47.06) | 28 (43.08) | 0.000 | 0.984 |
Family history of pancreatic cancer (yes/no) | 3 (17.65) | 14 (21.54) | 0.000 | 0.987 |
Table 2 Comparison of clinical characteristics between the two groups of patients, n (%)
Clinical characteristics | Non-PNI group (n = 17) | PNI group (n = 65) | t | P value |
Tumor location | ||||
Head | 7 (41.18) | 48 (73.85) | - | 0.033 |
Body | 6 (35.29) | 10 (15.38) | ||
Tail | 4 (23.53) | 7 (10.77) | ||
Tumor size (cm), mean ± SD | 4.06 ± 0.89 | 5.37 ± 1.85 | 4.158 | < 0.001 |
CA19-9 Level, mean ± SD | 260.67 ± 48.92 | 312.54 ± 57.62 | 3.745 | < 0.001 |
Overall survival (months), mean ± SD | 12.76 ± 3.21 | 9.85 ± 2.18 | 3.531 | 0.002 |
Abdominal pain | 3 (17.65) | 32 (49.23) | 4.279 | 0.039 |
Table 3 Comparison of pathological features between the two groups of patients, n (%)
Clinical characteristics | Non-PNI group (n = 17) | PNI group (n = 65) | t/χ2 | P value |
Pathological types | - | 0.019 | ||
Ductal adenocarcinoma | 9 (52.94) | 42 (64.62) | - | - |
Mucinous adenocarcinoma | 5 (29.41) | 23 (35.38) | ||
Adenosquamous carcinoma | 2 (11.76) | 0 (0.00) | ||
Small cell carcinoma | 1 (5.88) | 0 (0.00) | ||
Differentiation degree | - | < 0.001 | ||
Low | 2 (11.76) | 45 (69.23) | - | - |
Medium | 3 (17.65) | 14 (21.54) | ||
High | 12 (70.59) | 6 (9.23) | ||
Lymph node infiltration | 32.024 | < 0.001 | ||
Yes | 0 (0.00) | 51 (78.46) | - | - |
No | 17 (100.00) | 14 (21.54) |
Table 4 Correlation analysis of the occurrence of neural infiltration in pancreatic cancer and clinical pathological features
Items | r | P value |
Tumor location | -0.275 | 0.012 |
Tumor size (cm) | 0.351 | 0.001 |
CA19-9 Level | 0.376 | < 0.001 |
Overall survival (months) | -0.392 | < 0.001 |
Abdominal pain | 0.259 | 0.019 |
Differentiation degree | 0.656 | < 0.001 |
Lymph node infiltration | -0.275 | 0.012 |
- Citation: Lu XL, Ge C, Wang RC, Zang H. Correlation between perineural invasion and clinicopathological characteristics in pancreatic cancer. World J Gastrointest Oncol 2025; 17(9): 108277
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/108277.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.108277